METASTATIC GASTRIC CANCER: DESCRIPTION OF CLINICAL CASE
- Authors: Abramov M.E1, Bardovskaya K.S1, Mescheryakov A.A1, Medvedeva B.M1
-
Affiliations:
- Issue: No 17 (2016)
- Pages: 96-99
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/289382
- ID: 289382
Cite item
Abstract
Full Text
About the authors
M. E Abramov
FSBI “Russian Oncological Research Center n.a. N.N. Blokhin" of RMH PhD, Senior Researcher at the Department of Chemotherapy and Combined Therapy of Malignant Tumors FSBI «RORC n.a. N.N. Blokhin» of RMH Moscow
K. S Bardovskaya
Moscow State University n.a. M.V. Lomonosov Moscow
A. A Mescheryakov
FSBI “Russian Oncological Research Center n.a. N.N. Blokhin" of RMH Moscow
B. M Medvedeva
FSBI “Russian Oncological Research Center n.a. N.N. Blokhin" of RMH Moscow
References
- Globocan. Stomach cancer. Estimated incidence, mortlaity and prevalence worlwide http:// globocan.iarc.fr/old/FactSheets/cancers/ stomach-new.asp#INCIDENCE1.
- Sanford M. S-1 (Teysuno): A Review of Its Use in Advanced Gastric Cancer In Non-Asian Populations. Drugs 2013; 73(8):845-55.
- Ajani J., Rodrieguez W., Bodoky G., Moiseyenko V., Lichinitser M., Gorbunova V., Vynnychenko I., Garin A., Lang I., Falcon S. Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/ Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS Trial. J. Clin. Oncol. 2010;28(9): 1547-53.